key: cord-0855769-d5lyiyju
authors: Page, Lee K.; Staples, Karl J.; Spalluto, C. Mirella; Watson, Alastair; Wilkinson, Tom M. A.
title: Influence of Hypoxia on the Epithelial-Pathogen Interactions in the Lung: Implications for Respiratory Disease
date: 2021-03-24
journal: Front Immunol
DOI: 10.3389/fimmu.2021.653969
sha: 87f8e96d8051c3d591bd916ec9e51eb26dec03f7
doc_id: 855769
cord_uid: d5lyiyju

Under normal physiological conditions, the lung remains an oxygen rich environment. However, prominent regions of hypoxia are a common feature of infected and inflamed tissues and many chronic inflammatory respiratory diseases are associated with mucosal and systemic hypoxia. The airway epithelium represents a key interface with the external environment and is the first line of defense against potentially harmful agents including respiratory pathogens. The protective arsenal of the airway epithelium is provided in the form of physical barriers, and the production of an array of antimicrobial host defense molecules, proinflammatory cytokines and chemokines, in response to activation by receptors. Dysregulation of the airway epithelial innate immune response is associated with a compromised immunity and chronic inflammation of the lung. An increasing body of evidence indicates a distinct role for hypoxia in the dysfunction of the airway epithelium and in the responses of both innate immunity and of respiratory pathogens. Here we review the current evidence around the role of tissue hypoxia in modulating the host-pathogen interaction at the airway epithelium. Furthermore, we highlight the work needed to delineate the role of tissue hypoxia in the pathophysiology of chronic inflammatory lung diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease in addition to novel respiratory diseases such as COVID-19. Elucidating the molecular mechanisms underlying the epithelial-pathogen interactions in the setting of hypoxia will enable better understanding of persistent infections and complex disease processes in chronic inflammatory lung diseases and may aid the identification of novel therapeutic targets and strategies.

The airway epithelium is located at the interface between the internal and external environment and is strategically positioned to interact with the environment in a dynamic fashion. The pseudostratified mucosal barrier consisting of multiple cell types, constitutes the lung epithelium (1) . In a healthy state the airway epithelium plays an integral role in host defense through a physical and mechanical barrier, innate immune mediator production, and chemokine and cytokine production to recruit inflammatory cells for both propagation and resolution of the immune response (2) (3) (4) . The importance of the lung epithelium is exemplified in chronic inflammatory lung diseases, where epithelial cell dysfunction is associated with compromised immunity and chronic inflammation in the lung (5) (6) (7) (8) (9) . Structural and functional abnormalities in both the airway and alveolar epithelium have a significant impact on host defenses, immune/inflammatory response, and the repair process leading to progressive lung damage and impaired lung function.

Although an oxygen rich environment under normal physiological conditions, the lung mucosal surface is susceptible to conditions of oxygen deficiency or tissue hypoxia (10) during infection and inflammation, which occurs when cellular demand exceeds supply. Direct in vivo evidence has demonstrated that pulmonary infection is associated with profound local hypoxia (11) (12) (13) (14) . The occurrence of hypoxia during infection and associated inflammation is multifaceted and involves increased oxygen demand in order to satisfy the requirements of inflamed resident cells, and in some instances, multiplying pathogens (15) (16) (17) . Furthermore, infiltrating inflammatory cells such as neutrophils are thought to influence the tissue environment due to their metabolic cost. For example, it has been demonstrated that migration of neutrophils across the epithelium increases the transcriptional activity of hypoxia-inducible genes in epithelial cells, due to localized oxygen depletion, resulting in microenvironmental hypoxia which in turn, influences the resolution of inflammation (18) . Furthermore, beyond acute infection, chronic inflammatory respiratory diseases are also commonly associated with mucosal hypoxia. The airways of respiratory disease patients are characterized by chronic inflammation, structural changes and fibrosis, and airways obstruction through excessive mucus accumulation (19) (20) (21) (22) , which can lead to regions of local tissue hypoxia. Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. CF is characterized by airway mucus plugging, reduced mucus clearance due CFTR defects which renders the CF airways vulnerable to chronic infection and inflammation. The mucus filled CF airway, infected with P. aeruginosa is extremely hypoxic (23) . It is thought that thick stagnant mucus infiltrated with immune cells and multiplying pathogens creates a steep oxygen gradient within the mucus, exposing the underlying epithelial cells to marked hypoxia. Furthermore, the airway epithelium of mouse models of CF stained strongly with the specific hypoxia probe, pimonidazole hydrochloride (Hypoxyprobe, which binds at a threshold of ≤ 10 mmHg O 2 ) (24) , confirming that tissue hypoxia is present in this inflamed airway epithelium. Chronic obstructive pulmonary disease (COPD) is characterized by chronic airway inflammation and functional and structural alterations in the lung, primarily caused by long-term inhalation of harmful particles such as cigarette smoke (20, 25, 26) . Remodeling in the large airway in COPD, is accompanied by thickening and fibrosis of the subepithelial microvasculature and perivascular fibrosis (27), which may significantly reduce oxygenation of the airway epithelium. Increased expression of hypoxia-inducible factor (HIF)-1a is detected in the bronchial epithelium in COPD in areas of airway remodeling and goblet cell hyperplasia (28-30). Asthma, is another obstructive airway disease that involves chronic airway inflammation of the respiratory tract and excessive mucus production which is triggered by a variety of airborne insults including allergens, dust, smoking and respiratory pathogens. The increased expression of HIF-1a in lung mucosal biopsy specimens from asthmatic patients (31), may also indicate the presence of a tissue hypoxia in the asthmatic airway.

Pulmonary diseases associated with infection, excessive airway inflammation, airway obstruction, airway remodeling and emphysema can lead to decreased blood and also tissue oxygenation and consequently a fall in the partial pressure of oxygen in the arterial blood (10, 32, 33) . This is particularly evident in COVID-19 where hypoxia is a major risk factor for pneumonia and respiratory distress following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (34, 35). Furthermore, in COPD, the progression of the disease increases the risk of alveolar hypoxia and consequent hypoxemia (36). Ventilation/perfusion (V/Q) mismatch resulting from progressive airflow limitation and emphysematous destruction of the pulmonary capillary bed is the main factor contributing to hypoxemia in COPD patients (36). Hypoxemia associated with COPD contributes to reduced quality of life, diminished exercise tolerance, reduced skeletal muscle function, and ultimately increased risk of death (37). Moreover, exacerbations of COPD, which are associated with disease morbidity and mortality (38-41), are also frequently associated with deterioration in gas exchange and associated hypoxemia, due to increased tissue oxygen consumption and V/Q mismatch (42).

Whilst local tissue hypoxia and systemic hypoxia in the lung play a prominent role during infection and is present in chronic inflammatory respiratory diseases, the role of hypoxia at the level of the tissue in shaping the host-pathogen interactions in respiratory diseases is not fully understood. Here we review the current evidence around the role of tissue hypoxia in modulating the host-pathogen interaction at the lung epithelium. Furthermore, we highlight the essential work now needed to outline the role of tissue hypoxia in the pathophysiology of inflammatory lung diseases and emerging lung diseases such as COVID-19 and post-COVID-19 chronic lung disease.

For the host to be able respond to pathogens effectively and efficiently in hypoxic conditions, certain hypoxic regulatory mechanisms are essential. Thus, it is important to fully appreciate the significant effect that hypoxia has on downstream signaling pathways in tissue resident and infiltrating immune cells. The immune response under hypoxic conditions is governed by several pathways and metabolic activity, of which hypoxia-inducible factor (HIF), is the best characterized and termed the master regulator of the host response to hypoxia ( Figure 1 ). HIF is a DNA-binding transcription factor that associates with specific nuclear cofactors during hypoxia. HIF regulates hundreds of downstream genes which are involved in diverse biological pathways (43). The regulatory complex is comprised of HIF-1b, a constitutive subunit, and one of the HIF-a isoforms: HIF-1a or HIF-2a (44). In the presence of oxygen, HIF-a subunits undergo hydroxylation by prolyl hydroxylase domain (PHD) proteins and an asparagine hydroxylase known as the factor inhibiting HIF (FIH), in an oxygen and iron-dependent manner (45). Hydroxylated HIF-a is then targeted by the von Hippel-Lindau (VHL) protein, a substrate-recognition subunit of an ubiquitin-protein ligase which subsequently interacts with HIFa to undergo proteasomal degradation (46). During hypoxia, the activity of hydroxylase is reduced, leading to HIF stabilization, translocating to the nucleus from the cytoplasm, ultimately dimerizing with the HIF-1b subunit, to form the active HIF complex (47). Finally, the active forms of HIF recruit coactivator proteins to the hypoxia-response element, activating the transcription of target genes required for undergoing adaptations to hypoxia. HIF-1a is widely expressed in many innate immune cells including macrophages, neutrophils, dendritic cells and epithelial cells. Integral innate immune functions are preserved in hypoxic conditions through HIF. For example, the survival of neutrophils is extended in hypoxic conditions through HIF-1a and nuclear factor kappa-lightchain-enhancer of activated B cells (NF-kB) activation (48). Furthermore, it has been demonstrated that hypoxia-mediated HIF-1 activation of NF-kB in airway epithelial cells releases greater amounts of proinflammatory cytokines (49). However, hypoxia may also suppress the epithelial inflammatory response (50, 51). Exposure of murine airway epithelial cells to hypoxia has been shown to reduce the expression of key innate immune molecules through reduced NF-kB signaling (51). Moreover, the macrophage response to bacterial lipopolysaccharide (LPS) is enhanced under hypoxia, through HIF-1-mediated, increased toll-like receptor (TLR) gene expression, resulting in increased expression of cyclooxygenase-2, interleukin-6 and Regulated on Activation, Normal T Cell Expressed and Secreted (RANTES) (52, 53), suggesting that hypoxic conditions may contribute to the aggravated inflammatory responses during infection. Hypoxia also regulates other key transcription factors which contribute to the overall cellular response, including the major regulator of immunity NF-kB (54). Hypoxia-mediated activation of NF-kB is through decreased PHD-dependent hydroxylation of inhibitor of nuclear factor kappa B kinase subunit beta (IKKb), resulting in the phosphorylation-dependent degradation of IkBa FIGURE 1 | Regulation of HIF by hypoxia. During normoxia, HIF-a is hydroxylated by prolyl hydroxylase domain proteins (PHD) and factor inhibiting HIF (FIH), using molecular oxygen. This leads to HIF-a interacting with Von Hipple-Lindau (VHL), before being targeted for proteasomal degradation. During conditions of hypoxia, HIF-a hydroxylation by PHD/FIH is inhibited and HIF-a is not targeted for proteasomal degradation. HIF-a can translocate to the nucleus, where it binds with HIF-1b and recruits co-activators at the hypoxia response element (HRE) to initiate gene transcription. Created with BioRender.com. and liberation of NF-kB. Therefore, HIF-dependent and HIFindependent regulatory pathways in host cells that are regulated during tissue hypoxia may impact on the progression of chronic inflammatory respiratory diseases. Although hypoxia is essential in driving immunological processes and resolving respiratory infections, the relationship between immunity and hypoxia is delicately balanced. Resultant sustained aberrant inflammation and activity of immune cells leads to tissue damage and is a pathological hallmark of many chronic inflammatory respiratory diseases.

The airway epithelium forms the interface between the external environment and the internal milieu, making it a prime target for inhaled pathogens. However, the epithelium is not just a bystander, it forms an integral part of the innate immune system through being a physical barrier as well as releasing effectors to initiate and orchestrate immune and inflammatory responses (1) . Furthermore, dysfunction of the airway epithelium is associated with inflammatory lung diseases and increases the susceptibility to infection (55). Here we will discuss how hypoxia influences the epithelial-pathogen interactions in the lung, with important implications for respiratory disease ( Figure 2 ).

A fundamental lung mucosal defense mechanism is the secretion of mucus into the bronchial airway lumen to capture and trap invading pathogens, before being mechanically removed via mucociliary clearance (56, 57). The mucosal layer in the conducting airways exhibits a continuous layer of secreted proteins called mucins. Mucins are large glycoproteins formed of O-linked polysaccharides, which form a fluid-like barrier tethered to epithelial cells (57). The mucus-producing goblet cells function as the primary secretory cell, with the more abundant ciliated cells functioning as transporters to move the mucus up the airways for removal (58, 59). The ratio of secretory to ciliated cells is regulated both during normal physiological processes and also during infection to maintain optimal mucociliary function (60). However, chronic respiratory diseases are associated with pathological changes with the development of goblet cell hyperplasia, reduced expression of ciliated cells, mucus hypersecretion and mucus plugging (61-65). Sustained activation of disease associated signals such as from cigarette smoke, allergens and pathogens, promote the excessive differentiation towards goblet cell hyperplasia and mucus hypersecretion (66). Consequently, increased mucus production, dehydration of the airway surface liquid and mucus FIGURE 2 | Summary of the potential contributions of tissue hypoxia to the epithelial-pathogen interactions in respiratory diseases. Hypoxia is sensed by airway epithelial cells, that proceed to upregulate genes involved in the response to hypoxia through HIF-1a. The upregulated genes and proteins in response to HIF-1 transcription modulate several immune responses including impairing epithelial barrier function, reducing mucociliary clearance, modulating nutrient availability, and reducing anti-proteolytic enzymes. Hypoxia could also play important roles in pathogen colonization of the lung epithelium by mediating bacterial adherence through HIF-1-dependent mechanisms and enhance biofilm formation through bacterial-adaptive mechanisms. Finally, viral infected epithelial cells can be manipulated to upregulate glycolytic pathways through a HIF-1a-dependent mechanism, which consequently increases viral replication in the cells. Created with BioRender.com. plugging prevents the mucociliary functions of the innate immune system to adequately clear the airways of mucus and pathogens (67, 68) .

The development of mucus plugs has also been associated with cellular hypoxia of epithelial cells lining the airways, creating hypoxic niches within the adherent mucus and subjacent epithelial cells (24) . This is exemplified by mucus obstructed airway epithelial samples from COPD patients which are known to be hypoxic, exhibiting an increased expression of HIF-1a in areas of goblet cell hyperplasia, and the hypoxic mucus filled CF airways (23, 69) . Furthermore, analysis of CF and COPD lung tissue samples found that hypoxic airway epithelial necrosis in the mucus obstructed airways was a key trigger for neutrophilic inflammation, which may further exacerbate epithelial hypoxia (70) . Interestingly, HIF-1a has been shown to induce goblet cell hyperplasia and increase the expression of the mucin MUC5AC, via the epidermal growth factor receptor (EGFR) (71) (72) (73) . The EGFR is upregulated in the diseased airway epithelium and aberrant EGFR signaling has been implicated in the pathogenesis of asthma, COPD and CF (74, 75) . EGFR is an important protein involved in the epithelial repair process via the induction of epithelial migration, proliferation, differentiation, and extracellular matrix synthesis. However, the activation of EGFR, also leads to goblet cell hyperplasia, mucus hypersecretion, and overproduction of MUC5AC, which may exacerbate the pathological changes in respiratory diseases (76) (77) (78) (79) . Overproduction of the MUC5AC gene is a characteristic of many respiratory diseases including CF, asthma, and COPD (7, 80, 81) , creating hyper-concentrated mucus, which is thicker, more adherent and prone to mucus plugging (82) . Consequently, thicker and more adherent mucus may create further hypoxic niches within it. This has major implications not only for the progression of diseases but also for the host-pathogen interactions within the airways. Several bacterial pathogens, including non-typeable Haemophilus influenzae (NTHi), P. aeruginosa and Staphylococcus aureus, are able to bind to and utilize mucins as a mechanism for colonization of the lung (83) (84) (85) . Additionally, the hypoxic niches created in the mucus plugged airway may favour infectious organisms that gain energy efficiently under anaerobic conditions (86, 87) . The increased presence of anaerobic bacteria in the airway at more advanced stages of respiratory diseases have been demonstrated in lung microbiome studies (88) (89) (90) . The changes in microbiota in the diseased airway may negatively impact the progression of the disease (91) (92) (93) . For example, P. aeruginosa which is found in sputum more frequently in advanced stages of COPD is associated with exacerbations and increased risk of mortality (94, 95) . Furthermore the presence of obligate anaerobes have been linked to disease severity and inflammation in CF (96, 97) . Although still unknown, it may be postulated that mucolytic therapies which clear the airways of sputum, reduce mucus production and plugging and prevent airway obstruction could also play a role in reducing mucosal hypoxia. Alternatively, interventions which correct local hypoxia e.g. long-term oxygen therapy could hypothetically improve mucosal regulation and mucus hypersecretion and warrants investigation.

An important function of epithelial cells is to act as a physical barrier towards the outside environment. Tight junctions (TJ), adherens junctions (AJ) and desmosomes form the transcellular junctions (98) . These junctions are formed through intercellular junctional proteins including claudins, connexins, paranexins, cadherins, adhesions, and zonula occludins (ZO), which link to the actin cytoskeleton (99, 100) . This tightly regulated physical barrier not only controls paracellular ionic movements and nonpermeability of the epithelium (101, 102), but also prevents microbial compounds and airborne substances access to the body interior. The epithelial barrier is critical in the innate host defense as a loss of barrier function increases the susceptibility of the host to infection and injury by pathogens and proteases (103) . In addition, a pathological hallmark of several chronic inflammatory respiratory diseases, including asthma and COPD, is impaired epithelial barrier function and increased epithelial permeability, which may permit access for pathogens to the underlying submucosa (5, 7, (104) (105) (106) (107) . A number of factors have been implicated in epithelial barrier dysfunction including infection (108) (109) (110) and inhalation of noxious particles such as cigarette smoke (111) . Several studies have also demonstrated that exposing airway epithelial cells to hypoxia decreased the expression of apical cytoskeleton proteins actin and a-spectrin (112) , and also the expression of the TJ proteins ZO-1, claudin-4, occludin, and E-Cadherin (49, 112, 113), which consequently reduced epithelial barrier function. One possible mechanism is through the HIF-1a-mediated induction of vascular endothelial growth factor (VEGF), during hypoxia, which has been shown to increase epithelial permeability (114) . VEGF is a pleiotropic protein that regulates vascular angiogenesis and endothelial permeability and is an important adaptive mechanism to hypoxia, enhancing local vascularization and oxygen transport (115) , in addition to being an important mediator of inflammation (116) . The expression of VEGF is upregulated in the diseased airway epithelium, and has been implicated in airway remodeling processes (28, 117-119). Additionally, VEGF expression itself in the epithelium is a good indicator of local tissue hypoxia. Several studies have demonstrated that exposing airway epithelial cells to hypoxia, increased the expression of VEGF via HIF-1 (114, (120) (121) (122) . Though the induction of VEGF may be an adaptive response of angiogenesis when oxygen availability is reduced; paradoxically this may have pathological consequences in terms of epithelial barrier disruption. Thus, the hypoxia-HIF-1a-VEGF axis may be an important mechanism driving epithelial barrier disruption and increased permeability of the epithelium. Regarding the lung mucosal defense mechanisms, vulnerability to adherence and invasion of pathogens is increased by the leaky epithelial barrier, resulting in airway infection and subsequent inflammation. Therefore, hypoxia-mediated epithelial permeability may ultimately facilitate pathogen invasion of the epithelium and persistence in the airway epithelium.

Increased Bacterial Adherence to the Epithelium A crucial step for effective bacterial colonization and invasion involves adherence to host components in the airways (123, 124) . Platelet-activating factor receptor (PAFR) is one of the main epithelial cell-derived adhesion molecules used by both Grampositive and Gram-negative bacteria (125) (126) (127) (128) (129) . PAFR is a Gprotein coupled epithelial cell membrane receptor that naturally binds the phosphorylcholine (ChoP) ligand on the eukaryotic proinflammatory chemokine PAF (130) . Several species of airway bacteria display a host-derived zwitterionic/bipolar molecule ChoP on their bacterial walls, mimicking PAF to facilitate adherence to epithelial cells (131, 132) . PAFR is upregulated in the lungs of asthmatic and COPD patients (133) (134) (135) . The expression of PAFR is upregulated by noxious environmental particles such as cigarette smoke, electronic cigarettes, and biomass smoke exposure and exposure to pathogens (126, 128, 134, (136) (137) (138) (139) . Additionally, hypoxia prominently induces epithelial PAFR through HIF-dependent mechanisms (140) . The upregulation of PAFR in the lungs has been associated with increased adherence to the mucosal surfaces by respiratory pathogens, airway inflammation, speed of lung function decline, and development of pneumonia (126, 136, 138, 141) . Ultimately, microbial manipulation of PAFR, may be an important strategy for successful colonization and infection. The importance of ChoP-PAFR mediated bacterial adherence to epithelial cells has been confirmed by the use of PAFR antagonists, which have been shown to reduce bacterial adherence and invasion (127) (128) (129) 137) . Thus, the dynamic and integral role of HIF-1a in key immune functions opens complex questions regarding HIF-1a. However, there is still much needed research regarding the role of HIF-1a and PAFR.

The formation of multicellular microbial communities called biofilms is a critical step for pathogens during colonization of the lung, enabling survival and persistence in the challenging environment by attaching to a living surface (142, 143) . Many different microbes reside in biofilms and the majority of persistent infections involve biofilms (144) . Notably, biofilm communities enhance antimicrobial resistance to exogenous and endogenous effector molecules (145) . There are clear associations between biofilm formation, inflammation, and respiratory disease and biofilms have been implicated in the pathogenesis of COPD and CF (143, 144, 146, 147) and developing bronchopneumonia (148, 149) . Hypoxic conditions in the diseased lung may provide prime conditions for biofilm formation by P. aeruginosa which produce greater amounts of alginate under anaerobic conditions, a component involved in biofilm formation and protection against host immune responses (23, 150) . Additionally, P. aeruginosa grown under anaerobic or hypoxic conditions yields greater antibiotic resistance and biofilm formation suggesting that hypoxia may be a crucial component in bacterial persistence (151, 152) . The increase in antibiotic resistance appears to be due to hypoxia altering the stoichiometry of multidrug efflux pumps (153) . An important mechanism of antibiotic resistance is the expulsion of antibiotics through multidrug resistance efflux pump systems belonging to the resistance-nodulation-division family (154) . Therefore, these may be important mechanisms facilitating bacterial adaptive responses to hypoxia, increasing virulence and persistence in the diseased airways. There are also suggestions that local tissue hypoxia in the diseased lung is advantageous to anaerobic pathogens such as P. aeruginosa over other pathogens (155) . For example, biofilm formation itself contributes to local hypoxia of the diseased CF lung, which correlates with increased dependency on systems that mediate the uptake of reduced ferrous iron (Fe 2+ ) by P. aeruginosa (156) . Future studies investigating the role of hypoxia in biofilm formation with the use of ex vivo models would be valuable to understand the mechanisms of biofilm formation in the hypoxic airways (157) . Such models could also be used to investigate potential future biofilm-targeting therapeutics.

During inflammatory processes, a plethora of toxic inflammatory by-products are released by immune cells. For example, neutrophils infiltrating the site of infection have been implicated in causing excessive tissue damage through release of proteases and reactive oxygen species (ROS) (158) . Furthermore, macrophages produce matrix metalloproteinases (MMPs) during infectious processes, which can lead to excessive tissue damage (159) . Therefore, an adequate proteaseantiprotease balance is required to prevent excessive tissue damage and inflammation. Secretory leukocyte protease inhibitor (SLPI) is an important antiprotease, which prevents excessive tissue damage and inflammation (160) . This protein also possesses key antimicrobial functions against Gram-negative and Gram-positive bacteria (161, 162) . In vivo experiments have demonstrated that SLPI has the ability to dampen the macrophage associated inflammatory burden induced by LPS (163) . Furthermore, the pathogenesis of chronic inflammatory respiratory diseases are thought to involve a proteaseantiprotease imbalance (164, 165) . Sputum samples from COPD patients display lower levels of SLPI during infectious exacerbations (166, 167) , and lower levels of SLPI are associated with pronounced airway inflammation, susceptibility to infection, and disease severity (168, 169) . It has been demonstrated that hypoxia downregulates the expression of SLPI in airway epithelial cells via the upregulation of transforming growth factor (TGF)-b (170) . The expression and function of TGF-b is mediated by HIF-1a during hypoxia to promote cell growth and proliferation (171, 172) . Furthermore, TGF-b has been implicated in the vascular remodeling of hypoxia-induced pulmonary hypertension and is also upregulated in the lungs of CF and COPD patients (173) (174) (175) (176) . Inhibition of SLPI by TGF-b via the SMAD signaling pathway has been demonstrated at both the RNA and protein level (177, 178) . This modulation of complementary mechanisms by tissue hypoxia through alterations in TGF-b and thus SLPI expression could accentuate the protease-antiprotease imbalance and exacerbate inflammatory responses leading to increased tissue damage and progression of inflammatory lung diseases.

In the airways, the composition of the airway surface liquid (ASL) plays a critical role in the first line of defense against infection. In health, glucose concentrations in the fluid lining the ASL are maintained at 0.4 mM, about 12 times lower than the concentration of glucose in the bloodstream (179) . This is an important airway defense mechanism against infection, limiting bacterial growth by restricting nutrient availability (180) . However, in chronic inflammatory respiratory diseases including CF and COPD, the concentration of glucose in the ASL is increased (179, 181, 182) . Disruption of airway glucose homeostasis increases the availability of glucose as a nutrient source in the ASL for bacterial pathogens. Consequently, this has the potential to support proliferation of bacteria able to utilize glucose as a carbon source, increasing bacterial loads and altering bacterial communities. Evidence from in vitro (181, (183) (184) (185) , animal (186) , and human studies (187) , indicates that elevated ASL glucose stimulates the proliferation of P. aeruginosa, S. aureus, and other Gram-negative bacteria, which promote bacterial lung infections (188) (189) (190) . Additionally, elevated levels of glucose in the ASL is associated with exacerbation, inflammatory markers and bacterial load in COPD (181) . The principle mechanism thought to be limiting ASL glucose concentration are the epithelial TJs, which restrict paracellular glucose movement (191) . It has previously been shown that airway epithelial cell cultures infected with P. aeruginosa, resulted in TJ protein disruption, which was associated with increases in paracellular glucose flux, indicating the importance of epithelial barrier integrity in glucose airway homeostasis (192) . It is not yet known if hypoxia impacts ASL glucose concentrations but the presence of hypoxia in chronic inflammatory respiratory diseases and the profound impact of hypoxia on the epithelial barrier and TJ expression may indicate a role for tissue hypoxia and HIF-1. Increased glucose concentrations in the ASL may consequently facilitate nutrient availability for invading pathogens and increase their persistence in the airways. Thus, future experiments assessing the role of hypoxia and glucose airway homeostasis could be explored further in human ex vivo cell cultures.

Switching to glycolytic pathways may also be an important mechanism for viral replication in the lungs. During hypoxic stress, the rate of oxidative phosphorylation is reduced, switching cellular metabolism to the use of anaerobic glycolytic pathways via HIF-1a transcriptional activity (193). Airway epithelial cells respond in a similar fashion, displaying both aerobic and anaerobic glycolytic capacities (194) . Ouiddir et al., demonstrated that airway epithelial cells exposed to hypoxia induced a three-fold increase in the expression of the glucose transporter GLUT1, at both the mRNA and protein level (195) . The authors concluded that the epithelial cells ability to sustain ATP production during hypoxia was due to an increase in anaerobic glycolysis and increased glucose transport at the membrane level (195) . Additionally, hypoxia has been shown to induce the expression and activation of key glycolytic enzymes important for the breakdown of glucose, including pyruvate kinase, lactate dehydrogenase (194) , and glyceraldehyde phosphate dehydrogenase (GAPDH) (196) . More recently it was discovered that airway epithelial cells exposed to hypoxia resulted in an increase in HIF-1a (197) . In these hypoxic cells mitochondrial respiration was subsequently reduced as well as the rate of protein synthesis and demands for ATP, and the activity of GAPDH was increased (197) . The influenza H1N1 virus has been found to exploit this mechanism, mimicking the hypoxic response to stabilize HIF-1a during infection of airway epithelial cells (198) . This in turn, upregulates the expression of GLUT1, which may reprogram the host cellular glucose metabolism towards enhanced glycolysis to support nucleotide biosynthesis and lipogenesis for efficient viral replication. Rhinovirus infection has also been shown to induce metabolic alterations in host cells by increasing GLUT1 expression with increased glucose uptake and enhanced viral replication (199) . More recently, it was demonstrated that monocytes infected with SARS-CoV-2 resulted in mitochondrial ROS-mediated stabilization of HIF-1a and increased glycolysis (200) . The increase in glycolysis consequently promoted SARS-CoV-2 replication and cytokine expression. It is not yet known if similar processes take place in airway epithelial cells. However, it can be postulated that hypoxia in the airway during SARS-CoV-2 infection may increase the use of glycolytic enzymes through HIF-1 pathways which may support SARS-CoV-2 replication. In summary, tissue hypoxia and HIF-1 may play an important role in the pathogenesis of viral infections through the switching of glycolytic pathways which can support viral replication. This could be of particular importance in COVID-19 and respiratory diseases such as asthma and COPD where viral infections play a key role in exacerbations and disease progression (201, 202) .

Our understanding of the role of tissue hypoxia in mediating the epithelial-pathogen interactions in respiratory diseases is increasing. Hypoxia modulates several innate immune responses including impairing epithelial barrier function, reducing mucociliary clearance, modulating nutrient availability, and reducing protease inhibitors. Hypoxia could also play an important role in pathogen colonization of the lung epithelium through mediating bacterial adherence, internalization, biofilm formation, and viral replication. This review has highlighted potential future experimental work that may aid identification of new drug targets and the development of novel therapeutics. Developing a deeper understanding of the oxygen microenvironment within the lung is now key to create appropriate models and more accurately delineate mucosal hostpathogen interactions. Furthermore, understanding the impact of hypoxia-mediated modulation of transcription factors and the potential numerous implications for respiratory disease is essential. A greater understanding of the balance between beneficial and detrimental HIF-1 activation is also needed. Indeed, HIF-1 activity is critical for host response to pathogens and helps shape the innate and adaptive response. Thus, not all HIF-1 activation can be considered harmful and the therapeutic inhibition of this pathway must be balanced against its beneficial contribution. Nonetheless, targeting the HIF signaling pathway in chronic respiratory disease may still hold promise in effectively managing or delaying the progression of disease (203) . Novel therapeutics could be developed which specifically interfere with mRNA expression, protein synthesis, protein degradation, protein dimerization, DNA binding or transcriptional activity of HIF-1. Several in vitro studies have used various methods to inhibit or silence HIF-1 and have ameliorated its deleterious effects in disease models (73, 114, 140, 204) . Furthermore, the use of HIF-1a inhibitors for the treatment of patients infected with COVID-19 has recently been highlighted (205) . These potential strategies provide interesting opportunities to potentially modulate tissue hypoxia and lung mucosal host-pathogen interactions.

LP: conceptualization, investigation, literature searching, analysis, project administration, writing original draft, reviewing, and editing. KS: supervision, conceptualization, reviewing, and editing. MS: supervision, conceptualization, reviewing, and editing. AW: supervision, reviewing, and editing. TW: supervision, conceptualization, reviewing, and editing. All authors contributed to the article and approved the submitted version. (2) 

Innate immunity in the respiratory epithelium

Control of local immunity by airway epithelial cells

Respiratory epithelial cells orchestrate pulmonary innate immunity

Dynamics of IFN-b Responses During Respiratory Viral Infection: Insights for Therapeutic Strategies

Defective epithelial barrier function in asthma

The Respiratory Epithelium in COPD

Airway Epithelium Dysfunction in Cystic Fibrosis and COPD

Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease

Relationships between mucosal antibodies, non-typeable Haemophilus influenzae (NTHi) infection and airway inflammation in COPD

Alveolar Hypoxia-Induced Pulmonary Inflammation: From Local Initiation to Secondary Promotion by Activated Systemic Inflammation

Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions

In vivo hypoxia and a fungal alcohol dehydrogenase influence the pathogenesis of invasive pulmonary aspergillosis

Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates

Hypoxia and tissue destruction in pulmonary TB

The impact of hypoxia on bacterial infection

Hypoxia Modulates Infection of Epithelial Cells by Pseudomonas aeruginosa

Hypoxia and HIF-1 activation in bacterial infections

Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation

Distinct emphysema subtypes defined by quantitative CT analysis are associated with specific pulmonary matrix metalloproteinases

Airway and systemic inflammation and decline in lung function in patients with COPD

Impact of radiologically stratified exacerbations: Insights into pneumonia aetiology in COPD

Relationship between pulmonary matrix metalloproteinases and quantitative CT markers of small airways disease and emphysema in COPD

Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients

Development of chronic bronchitis and emphysema in b-epithelial Na+ channel-overexpressing mice

Impact and associations of eosinophilic inflammation in COPD

Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease

Mucociliary clearance: Pathophysiological aspects

Hypoxia-inducible factor-1 signalling promotes goblet cell hyperplasia in airway epithelium

Hypoxic epithelial necrosis triggers neutrophilic inflammation via IL-1 receptor signaling in cystic fibrosis lung disease

Regulation of cigarette smoke-mediated mucin expression by hypoxia-inducible factor-1a via epidermal growth factor receptor-mediated signaling pathways

Hypoxia induces mucin expression and secretion in human bronchial epithelial cells

IL-1b upregulates Muc5ac expression via NF-kB-induced HIF-1a in asthma

Expression of epidermal growth factors and their receptors in the bronchial epithelium off subjects with chronic obstructive pulmonary disease

Targeting EGFR signalling in chronic lung disease: Therapeutic challenges and opportunities

Epidermal growth factor system regulates mucin production in airways

Oxidative Stress Causes Mucin Synthesis Via Transactivation of Epidermal Growth Factor Receptor: Role of Neutrophils

Neutrophil Defensins Enhance Lung Epithelial Wound Closure and Mucin Gene Expression in Vitro

MUC1 contributes to goblet cell metaplasia and MUC5AC expression in response to cigarette smoke in vivo

Role of the mucins in pathogenesis of COPD: implications for therapy

Upregulation of MUC5AC by VEGF in human primary bronchial epithelial cells: implications for asthma

Excess mucus viscosity and airway dehydration impact COPD airway clearance

Staphylococcus aureus binding to human nasal mucin

Haemophilus influenzae lysate induces aspects of the chronic obstructive pulmonary disease phenotype

Host Mucin Is Exploited by Pseudomonas aeruginosa To Provide Monosaccharides Required for a Successful Infection

Pediatric cystic fibrosis sputum can be chemically dynamic, anoxic, and extremely reduced due to hydrogen sulfide formation

Exposing the Three-Dimensional Biogeography and Metabolic States

Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa

Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: Interaction between intestinal and respiratory tracts and impact of nutritional exposures

The Lung Microbiome in Moderate and Severe Chronic Obstructive Pulmonary Disease

Relationships among bacteria, upper airway, lower airway, and systemic inflammation in COPD

Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trial

Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease

Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease

Pseudomonas aeruginosa in adults with chronic obstructive pulmonary disease

Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis

The role of anaerobic bacteria in the cystic fibrosis airway

Junctional Interplay in Lung Epithelial Barrier Function

Inflammatory hypoxia: Role of hypoxiainducible factor

The airway epithelium: More than just a structural barrier

The tight junction: A multifunctional complex

Crystal structure of a claudin provides insight into the architecture of tight junctions

Claudin-18 deficiency results in alveolar barrier dysfunction and impaired alveologenesis in mice

Abnormalities in Airway Epithelial Junction Formation in Chronic Obstructive Pulmonary Disease

Airway epithelial barrier dysfunction in chronic obstructive pulmonary disease: Role of cigarette smoke exposure

Intermittent exposure to whole cigarette smoke alters the differentiation of primary small airway epithelial cells in the air-liquid interface culture

Cigarette smoke alters primary human bronchial epithelial cell differentiation at the air-liquid interface

The histopathology of fatal untreated human respiratory syncytial virus infection

Effect of Preexisting Serum and Mucosal Antibody on Experimental Respiratory Syncytial Virus (RSV) Challenge and Infection of Adults

Nontypeable Haemophilus influenzae (NTHi) directly interfere with the regulation of E-cadherin in lung epithelial cells

Hydrogen sulfide inhibits cigarette smoke-induced inflammation and injury in alveolar epithelial cells by suppressing PHD2/HIF-1a/MAPK signaling pathway

Hypoxiainduced cytoskeleton disruption in alveolar epithelial cells

Hypoxia increases epithelial permeability in human nasal epithelia

Hypoxia modulates epithelial permeability via regulation of vascular endothelial growth factor in airway epithelia

HIF-1 a: a master regulator of innate host defenses?

Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung

Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation

Expression of vascular endothelial growth factor and hypoxia-inducible factor in the airway of asthmatic patients

Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease

Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo

Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia: Modulation of gene expression by nitric oxide

Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells

Host-pathogen interactions of nontypeable Haemophilus influenzae: from commensal to pathogen

Cotranscriptomes of initial interactions in vitro between streptococcus pneumoniae and human pleural mesothelial cells

Platelet activating factor receptor: Gateway for bacterial chronic airway infection in chronic obstructive pulmonary disease and potential therapeutic target

Ecigarette vapour enhances pneumococcal adherence to airway epithelial cells

An antagonist of the platelet-activating factor receptor inhibits adherence of both nontypeable Haemophilus influenzae and Streptococcus pneumoniae to cultured human bronchial epithelial cells exposed to cigarette smoke

Novel Phosphorylcholine-Containing Protein of Pseudomonas aeruginosa Chronic Infection Isolates Interacts with Airway Epithelial Cells

Particulate matter exposure promotes Pseudomonas aeruginosa invasion into airway epithelia by upregulating PAFR via the ROS − mediated PI3K pathway

Platelet-activating factor receptor

Binding of the non-typeable Haemophilus influenzae lipooligosaccharide to the PAF receptor initiates host cell signalling

Bacterial exploitation of phosphorylcholine mimicry suppresses inflammation to promote airway infection

Airway epithelial platelet-activating factor receptor expression is markedly upregulated in chronic obstructive pulmonary disease

Bronchial platelet-activating factor receptor in chronic obstructive pulmonary disease

Expression of platelet-activating factor receptor mRNA in human and guinea pig lung

Pneumococcal infection of respiratory cells exposed to welding fumes; Role of oxidative stress and HIF-1 alpha

Cow Dung Biomass Smoke Exposure Increases Adherence of Respiratory Pathogen Nontypeable Haemophilus influenzae to Human Bronchial Epithelial Cells

Repeated Exposure to Streptococcus pneumoniae Exacerbates Chronic Obstructive Pulmonary Disease

Vitamin D attenuates rhinovirus-induced expression of intercellular adhesion molecule-1 (ICAM-1) and platelet-activating factor receptor (PAFR) in respiratory epithelial cells

Hypoxia-inducible Factor-dependent Regulation of Platelet-activating Factor Receptor as a Route for Gram-Positive Bacterial Translocation across Epithelia. Nusrat A, editor

Effects of Rhinovirus Infection on the Adherence of Streptococcus pneumoniae to Cultured Human Airway Epithelial Cells

Host responses to mucosal biofilms in the lung and gut

Nontypeable Haemophilus influenzae biofilms: role in chronic airway infections

Bacterial biofilm and associated infections

Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease

Expression of a peroxiredoxinglutaredoxin by Haemophilus influenzae in biofilms and during human respiratory tract infection

Haemophilus influenzae Stimulates ICAM-1 Expression on Respiratory Epithelial Cells

Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients

risk factors and burden of community-acquired pneumonia in COPD patients: A population database study using linked health care records

Anaerobic production of alginate by Pseudomonas aeruginosa: Alginate restricts diffusion of oxygen

Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions

Effects of oxygen on in-vitro biofilm formation and antimicrobial resistance of Pseudomonas aeruginosae

Hypoxia increases antibiotic resistance in Pseudomonas aeruginosa through altering the composition of multidrug efflux pumps

Multidrug-resistance efflux pumps -Not just for resistance

Interactions between Pseudomonas aeruginosa and Staphylococcus aureus during co-cultivations and polymicrobial infections

Ferrous iron is a significant component of bioavailable iron in cystic fibrosis airways

A Novel Lung Explant Model for the Ex Vivo Study of Efficacy and Mechanisms of Anti-Influenza Drugs

Neutrophil-mediated pulmonary vascular injury. Synergistic effect of trace amounts of lipopolysaccharide and neutrophil stimuli on vascular permeability and neutrophil sequestration in the lung

Role of matrix metalloproteinases in models of macrophage-dependent acute lung injury: Evidence for alveolar macrophage as source of proteinases

Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor

Antibacterial activity of antileukoprotease

Antileukoprotease in human skin: An antibiotic peptide constitutively produced by keratinocytes

Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice

Protease-antiprotease imbalance in the lungs of children with cystic fibrosis

Pathogenic triad in COPD: Oxidative stress, protease-antiprotease imbalance, and inflammation

Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary disease

Effects of bacterial infection on airway antimicrobial peptides and proteins in COPD

Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease

Antimicrobial peptides, disease severity and exacerbations in bronchiectasis

Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-b1

Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor and transforming growth factor-bdependent mechanisms

Hypoxia-inducible factor-1a mediates TGF-b-induced PAI-1 production in alveolar macrophages in pulmonary fibrosis

Transforming growth factor b1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease

Increased expression of transforming growth factor-b1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD)

Myofibroblast Differentiation and Enhanced Tgf-B Signaling in Cystic Fibrosis Lung Disease

Cross regulation between hypoxia-inducible transcription factor-1a (HIF-1a) and transforming growth factor (TGF)-ß1 mediates nickel oxide nanoparticles (NiONPs)-induced pulmonary fibrosis

Transforming growth factor-b1 is a potent inhibitor of secretory leukoprotease inhibitor expression in a brochial epithelial cell line

Downregulation of Secretory Leukocyte Proteinase Inhibitor in Chronic Obstructive Lung Disease: The Role Of TGF-b/Smads Signaling Pathways

Hyperglycemia and cystic fibrosis alter respiratory fluid glucose concentrations estimated by breath condensate analysis

Airway Glucose Homeostasis: A New Target in the Prevention and Treatment of Pulmonary Infection

Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease

18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases

Increased airway glucose increases airway bacterial load in hyperglycaemia

Metformin reduces airway glucose permeability and hyperglycaemiainduced Staphylococcus aureus load independently of effects on blood glucose

Elevated Paracellular Glucose Flux across Cystic Fibrosis Airway Epithelial Monolayers Is an Important Factor for Pseudomonas aeruginosa Growth

Dapagliflozin-lowered blood glucose reduces respiratory Pseudomonas aeruginosa infection in diabetic mice

Glucose in bronchial aspirates increases the risk of respiratory MRSA in intubated patients

Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis

Glucose depletion in the airway surface liquid is essential for sterility of the airways

Haemophilus influenzae Glucose Catabolism Leading to Production of the Immunometabolite Acetate Has a Key Contribution to the Host Airway-Pathogen Interplay

Proinflammatory Mediators Disrupt Glucose Homeostasis in Airway Surface Liquid

Metformin prevents the effects of Pseudomonas aeruginosa on airway epithelial tight junctions and restricts hyperglycaemia-induced bacterial growth

Semenza GL. Regulation of metabolism by hypoxia-inducible factor 1

Bioenergetic Pattern of Isolated Type II Pneumocytes in Air and during Hypoxia

Hypoxia upregulates activity and expression of the glucose transporter GLUT1 in alveolar epithelial cells

Hypoxia increases glyceraldehyde-3-phosphate dehydrogenase transcription in rat alveolar epithelial cells

Hypoxia decreases cellular ATP demand and inhibits mitochondrial respiration of A549 cells

Influenza A virus (H1N1) triggers a hypoxic response by stabilizing hypoxia-inducible factor-1a via inhibition of proteasome

Rhinovirus induces an anabolic reprogramming in host cell metabolism essential for viral replication

Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1a/Glycolysis-Dependent Axis

Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease

Influenza vaccination for patients with chronic obstructive pulmonary disease: Understanding immunogenicity, efficacy and effectiveness

If it's not one thing, HIF's another: immunoregulation by hypoxia inducible factors in disease

Cigarette smoke extract induces a phenotypic shift in epithelial cells; involvement of HIF1a in mesenchymal transition

A key feature of COVID-19 launching activation of HIF-1 and cytokine storm